The Cigna Group
CI
$315.99
$3.311.06%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 65.26B | 65.37B | 63.61B | 60.20B | 56.97B |
| Total Other Revenue | 238.00M | 277.00M | 85.00M | 321.00M | 290.00M |
| Total Revenue | 65.50B | 65.65B | 63.69B | 60.52B | 57.26B |
| Cost of Revenue | 58.90B | 59.19B | 57.09B | 54.01B | 50.87B |
| Gross Profit | 6.61B | 6.46B | 6.60B | 6.52B | 6.38B |
| SG&A Expenses | 3.80B | 3.74B | 3.52B | 3.63B | 3.67B |
| Depreciation & Amortization | 422.00M | 424.00M | 436.00M | 420.00M | 423.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.12B | 63.35B | 61.05B | 58.06B | 54.96B |
| Operating Income | 2.39B | 2.30B | 2.64B | 2.47B | 2.29B |
| Income Before Tax | 1.65B | 2.01B | 1.19B | 1.99B | 79.00M |
| Income Tax Expenses | 239.00M | 473.00M | 367.00M | 360.00M | 291.00M |
| Earnings from Continuing Operations | 1.41B | 1.54B | 825.00M | 1.63B | -212.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -86.00M | -112.00M | -86.00M | -81.00M | -65.00M |
| Net Income | 1.32B | 1.42B | 739.00M | 1.55B | -277.00M |
| EBIT | 2.39B | 2.30B | 2.64B | 2.47B | 2.29B |
| EBITDA | 3.06B | 2.94B | 3.29B | 3.21B | 3.03B |
| EPS Basic | 4.88 | 5.13 | 2.65 | 5.51 | -0.97 |
| Normalized Basic EPS | 4.35 | 3.89 | 4.80 | 4.38 | 4.07 |
| EPS Diluted | 4.85 | 5.12 | 2.63 | 5.45 | -0.97 |
| Normalized Diluted EPS | 4.32 | 3.89 | 4.75 | 4.34 | 4.07 |
| Average Basic Shares Outstanding | 270.87M | 277.78M | 278.46M | 281.13M | 286.47M |
| Average Diluted Shares Outstanding | 272.95M | 277.78M | 281.40M | 284.05M | 286.47M |
| Dividend Per Share | 1.51 | 1.40 | 1.40 | 1.40 | 1.40 |
| Payout Ratio | 31.14% | 26.97% | 52.77% | 25.32% | -144.77% |